ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03298984
Brief Title: Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).

First Submitted : September 27, 2017
First Submitted that Met QC Criteria : September 27, 2017
First Posted : October 2, 2017

Last Update Submitted that Met QC Criteria : January 11, 2018
Last Update Posted : January 16, 2018